Recent Company News

• 05:10 PM ET Oct 07, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 02:33 AM ET Oct 21, 2025
  

  Bayer AG will present methods and baseline characteristic data from global Phase III OCEANIC-STROKE study with investigational agent asundexian at upcoming World Stroke Congress (€27.43, 0.00)

• 10:57 AM ET Oct 20, 2025
  

  StreetAccount Summary - Private company transactions for the week ended 18-Oct

• 10:05 PM ET Oct 17, 2025
  

  StreetAccount Sector Summary - Healthcare Weekly Recap

• 02:44 PM ET Oct 17, 2025
  

  StreetAccount Summary: Notable Drug Events expected for the week of 19-Oct

• 08:46 AM ET Oct 07, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 06:07 PM ET Oct 16, 2025
  

  FDA grants orphan drug designation to AskBio for treatment of Pompe disease (€27.09, 0.00)

• 01:50 PM ET Oct 10, 2025
  

  StreetAccount Summary: Notable Drug Events expected for the week of 12-Oct